注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Avian Influenza A H7N9 Neuraminidase Antibody   

Avian Influenza A H7N9 Neuraminidase Antibody

     
  • 10 - Avian Influenza A H7N9 Neuraminidase Antibody ASC11807
    H7N9 Neuraminidase antibody detects 10 ng of H7N9 [Influenza A virus (A/Shanghai/02/2013(H7N9))] Neuraminidase peptide, and not 10 ng of H7N9 [Influenza A virus (A/blue-winged teal/Ohio/566/2006(H7N9))] Neuraminidase peptide in ELISA.
  • 产品详情
  • 实验流程
  • 背景知识
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
E
Primary Accession R4NFR6
Other Accession AGL44440, 496493393
Reactivity Virus
Host Rabbit
Clonality Polyclonal
Isotype IgG
Concentration (mg/ml) 1 mg/mL
Conjugate Unconjugated
Application Notes Avian Influenza A H7N9 Neuraminidase antibody can be used for detection of Avian Influenza A H7N9 Neuraminidase by ELISA at 1 µg/ml.
Additional Information
Target/Specificity NA; virus
Reconstitution & Storage Avian Influenza A H7N9 Neuraminidase antibody can be stored at 4℃ for three months and -20℃, stable for up to one year.
PrecautionsAvian Influenza A H7N9 Neuraminidase Antibody is for research use only and not for use in diagnostic or therapeutic procedures.

For Research Use Only. Not For Use In Diagnostic Procedures.

Protein Information
Research Areas

BACKGROUND

Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

REFERENCES

Thompson WW, Shay DK, Weintraub, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-186.
Alexander DJ. A review of avian influenza. Proceedings of the European Society for Veterinary Virology (ESVV) Symposium on Influenza Viruses of Wild and Domestic Animals. Vet. Microbiol. 2000; 74:3-13.
Wiwanitkit V. H7N9 influenza: the emerging infectious disease. N. Am. J. Med. Sci. 2013; 5:395-8.

FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价